Skip to content

Effect of a Persica-containing toothpaste in plaque induced gingivitis

Comparative evaluation of the effectiveness of a Persica-containing toothpaste over a Persica-free toothpaste in patients with plaque-induced gingivitis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT20080831001150N6
Enrollment
130
Registered
2022-10-16
Start date
2022-12-22
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plaque induced gingivitis. Acute gingivitis, plaque induced

Interventions

Intervention 1: Intervention group: On the first appointment after the clinical periodontal examinations, the patient will receive phase one treatment: Root planing and scaling (SRP), and then will be

Sponsors

Goltash company, Paksan
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Ages 18 to 75 The patient must have at least 20 teeth without crown restorations or cavities Patient of plaque induces gingivitis BIP positive or a change in gingival margin color The patient is willing to participate

Exclusion criteria

Exclusion criteria: The cause of gingivitis isn't plaque Patient has been taking antibiotics or anti inflammatory drugs repeatedly within the past 3 months Pregnant or lactating women Patient with systemic or immunity problems Smoker Pocket depth > 4mm Patient with clinical attachment loss Patient with not acceptable partial prosthesis, restorations or bridges Patient using orthodontic appliances Patient with a history of allergic reactions to chemicals Patient using mouth rinse

Design outcomes

Primary

MeasureTime frame
Modified gingival index. Timepoint: Baseline; 1 week; 2 weeks; 1 month; 2 months after phase 1 treatment. Method of measurement: Clinical examination.;Full mouth plaque score. Timepoint: Baseline; 1 week; 2 weeks; 1 month; 2 months after phase 1 treatment. Method of measurement: Clinical examination.;Full mouth bleeding score. Timepoint: Baseline; 1 week; 2 weeks; 1 month; 2 months after phase 1 treatment. Method of measurement: Clinical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHouriyeh Radanfar

Tehran University of Medical Sciences

hradanfar@gmail.com+98 21 3631 6736

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026